Tilray Announces Adjournment of Special Meeting of Stockholders to September 10, 2021
August 19 2021 - 11:15AM
Business Wire
Votes already cast point to support for both
the Authorized Shares Proposal and the Governance Proposals
Tilray urges stockholders to vote immediately
in support of long-term value creation
Tilray, Inc. (“Tilray” or the “Company”) (NASDAQ | TSX: TLRY), a
leading global cannabis-lifestyle and consumer packaged goods
company, today convened and then adjourned the Special Meeting of
Stockholders intended to approve two shareholder proposals: (1) a
proposal to increase the authorized number of shares of common
stock (“Authorized Shares Proposal”); and (2) a number of
governance enhancements to increase stockholder rights (the
“Governance Proposals”). The Special Meeting was adjourned to
September 10, 2021, at 11:00 a.m. Eastern Time.
Based on a preliminary assessment of votes received by the
Company’s proxy solicitor, the majority of votes cast to date
support both the Authorized Shares Proposal and the Governance
Proposals. The adjournment of the Special Meeting is intended to
provide Tilray with additional time to solicit proxies and to give
Tilray shareholders additional time to consider information
relevant to Proposal 1, including the announcement of Tilray’s
strategic investment in MedMen convertible notes and the importance
of Proposal 1 in enabling Tilray to optimize the execution of that
transaction.
Irwin D. Simon, Tilray’s Chairman and CEO said, “We urge
stockholders who have not yet voted to participate in the success
of their investment in Tilray by voting FOR all proposals on the agenda for the
Special Meeting. By doing so, stockholders will be actively
supporting Tilray’s ability to pursue and optimize growth
opportunities, including our game-changing investment in MedMen
convertible notes, expand and generate strong performance, increase
stockholder rights and, ultimately, drive stockholder value. No
matter how many or how few shares you own, your participation will
enable us to maximize our potential to create value for our
stockholders in the near-term and in the future.”
The approval of the Authorized Shares Proposal requires the
affirmative vote of holders of at least a majority of the voting
power of shares outstanding and entitled to vote. The record date
for the adjourned Special Meeting remains June 22, 2021.
Stockholders who have already voted do not need to recast their
votes unless they wish to change their vote. Stockholders who have
not already voted or wish to change their vote are strongly
encouraged to do so promptly using the instructions provided in
their voting instruction form or proxy card.
If you have any questions, or need any assistance in voting
your shares, please contact Morrow Sodali LLC at (833) 497-7395
toll-free in the U.S. and Canada, or (203) 658-9400 or by email at
TLRY@info.morrowsodali.com.
HELP TILRAY GROW! VOTE “FOR” TODAY!
About Tilray
Tilray, Inc. is a leading global cannabis-lifestyle and consumer
packaged goods company with operations in Canada, the United
States, Europe, Australia, and Latin America that is changing
people’s lives for the better – one person at a time – by inspiring
and empowering the worldwide community to live their very best life
by providing them with products that meet the needs of their mind,
body, and soul and invoke a sense of wellbeing. Tilray’s mission is
to be the trusted partner for its patients and consumers by
providing them with a cultivated experience and health and
wellbeing through high-quality, differentiated brands and
innovative products. A pioneer in cannabis research, cultivation,
and distribution, Tilray’s unprecedented production platform
supports over 20 brands in over 20 countries, including
comprehensive cannabis offerings, hemp-based foods, and alcoholic
beverages.
For more information about Tilray, Inc., visit:
http://www.Tilray.com
Forward-Looking Statements
Certain statements in this communication that are not historical
facts constitute forward-looking information or forward-looking
statements (together, “forward-looking statements”) under Canadian
securities laws and within the meaning of Section 27A of the
Securities Act of 1933, as amended, and Section 21E of the
Securities Exchange Act of 1934, as amended, that are intended to
be subject to the “safe harbor” created by those sections and other
applicable laws. Forward-looking statements can be identified by
words such as “forecast,” “future,” “should,” “could,” “enable,”
“potential,” “contemplate,” “believe,” “anticipate,” “estimate,”
“plan,” “expect,” “intend,” “may,” “project,” “will,” “would” and
the negative of these terms or similar expressions, although not
all forward-looking statements contain these identifying words.
Forward-looking statements include statements regarding our
intentions, beliefs, projections, outlook, analyses or current
expectations concerning, among other things, the need for an
increase in authorized shares of common stock from 743,333,333
shares to 990,000,000 shares and the potential negative impacts to
the company if the corresponding proposal is not approved. Certain
material factors, estimates, goals, projections or assumptions were
used in drawing the conclusions contained in the forward-looking
statements throughout this communication. Many factors could cause
actual results, performance or achievement to be materially
different from any forward-looking statements, and other risks and
uncertainties not presently known to the Company or that the
Company deems immaterial could also cause actual results or events
to differ materially from those expressed in the forward-looking
statements contained herein. For a more detailed discussion of
these risks and other factors, see the most recently filed annual
information form of Aphria and the Annual Report on Form 10-K (and
other periodic reports filed with the SEC) of Tilray made with
applicable securities regulatory authorities and available on SEDAR
and EDGAR. The forward-looking statements included in this
communication are made as of the date of this communication and the
Company does not undertake any obligation to publicly update such
forward-looking statements to reflect new information, subsequent
events or otherwise unless required by applicable securities
laws.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210819005575/en/
For media inquiries, please contact: Berrin Noorata
news@tilray.com For investor inquiries, please contact:
Raphael Gross 203-682-8253 Raphael.Gross@icrinc.com
Tilray Brands (NASDAQ:TLRY)
Historical Stock Chart
From Aug 2024 to Sep 2024
Tilray Brands (NASDAQ:TLRY)
Historical Stock Chart
From Sep 2023 to Sep 2024